Pseudallescheria boydii is an emerging
opportunistic pathogen.
Immune response is characterized by
TLR2 recognition of
P. boydii derived α-glucans, while
TLR4 mediates the recognition of
P. boydii derived
rhamnomannans. Human infection takes one of two forms: mycetoma (99% of infections), a
chronic,
subcutaneous disease, and
pseudallescheriasis, which includes all other forms of the disease commonly presented in the
central nervous system, lungs, joints and bone. The former can also be distinguished by the presence of
sclerotia, or granules, which are typically absent in pseudallescheriasis-type infections. Infection is initiated via inhalation or traumatic implantation in the skin. Infection can lead to arthritis,
otitis, endocarditis,
sinusitis, and other manifestations. Masses of hyphae can form "fungus balls" in the lungs. While "fungus balls" can also form in other organs, they are commonly derived from host necrotic tissue resulting from nodular infarction and thrombosis of lung vessels following infection. This species is second in prevalence after
Aspergillus fumigatus as a fungal pathogen in
cystic fibrosis patients. It causes allergic bronchopulmonary disease and chronic lung lesions that resemble aspergillosis. Infections can also occur in immunocompetent individuals, usually in the lungs and upper respiratory tract. Infections in the CNS, which are rare, present as neutrophilic meningitis or multiple brain abscesses and have a mortality rate of up to 75%. Infections have also been observed in animals, notably corneal infection, abdominal mycetoma and disseminated infections in dogs and horses. Transient colonization is more likely than disease. However, invasive pseudoallescheriasis can be found in patients with prolonged
neutropenia, high-dose corticosteroid therapy and
allotransplantation of bone marrow.
Pseudallescheria boydii has also been implicated in pneumonia subsequent to near-drowning events with infection developing anywhere between a few weeks to several months after exposure yielding high mortality. Dissemination of the organism to the
central nervous system has been observed in some cases. This species is also known as a non-invasive colonist of the external ear and airways of patients with poor lung or sinus clearance, and the first documented case of human pseudallescheriasis involved the ear canal. It has also been implicated in infection of joints following traumatic injury, and these infections can progress to osteomyelitis. Infections of the skin and cornea have also been reported. Typical host-related risk factors for infection include
lymphopenia, steroid treatment, serum albumin levels of < 3 mg/dL and
neutropenia. ==Diagnosis==